A detailed history of International Assets Investment Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, International Assets Investment Management, LLC holds 84,682 shares of RXRX stock, worth $648,664. This represents 0.04% of its overall portfolio holdings.

Number of Shares
84,682
Previous 13,500 527.27%
Holding current value
$648,664
Previous $101 Million 87.31%
% of portfolio
0.04%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$5.92 - $8.6 $421,397 - $612,165
71,182 Added 527.27%
84,682 $12.9 Million
Q2 2024

Jul 30, 2024

BUY
$7.35 - $10.05 $99,225 - $135,675
13,500 New
13,500 $101 Million
Q4 2023

Jan 24, 2024

BUY
$5.09 - $10.79 $85,318 - $180,861
16,762 New
16,762 $1.7 Million
Q3 2023

Oct 04, 2023

BUY
$6.59 - $15.86 $7,249 - $17,446
1,100 New
1,100 $8,000

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.38B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.